Back to User profile » Dr Michael P. Ero

Paper published by Dr Michael P. Ero:


Clinical Trial Report

Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial

Jensen GS, Lenninger M, Ero MP, Benson KF

Integrated Blood Pressure Control 2016, 9:95-104

Published Date: 13 October 2016